Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Salavert

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
Enfermedades Infecciosas Y Microbiologia Clinica|December 1, 1994
[Hip prosthesis infection: diagnostic approach and treatment of 27 cases]M Salavert, J Martínez, C Sánchez, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 29, 2015
Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patientsS Grau, J C Pozo, E Romá, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infections (CDI) also Known as Clostridium Difficile-Associated Diarrhoea (CDAD) in SpainJ Cobo Reinoso, S Grau Cerrato, J Mensa Pueyo, et al.
The British Journal of Dermatology|February 5, 2008
Amyloid elastosis: a new case studied extensively by electron microscopy and immunohistochemistryB Bocquier, M D'Incan, J Joubert, et al.
Medicina Cutanea Ibero-Latino-Americana|January 1, 1990
[Cutaneo-visceral leishmaniasis: a new opportunistic infection in patients infected by HIV]R Botella Estrada, O Sanmartín Jiménez, M I Febrer Bosch, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|January 20, 2007
Group A streptococcal bacteremia: outcome and prognostic factorsM Vallalta Morales, C J Soriano Navarro, M Salavert Lletí, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 27, 2015
Economic assessment of fidaxomicin for the treatment of Clostridium difficile infection (CDI) in special populations (patients with cancer, concomitant antibiotic treatment or renal impairment) in SpainC Rubio-Terrés, J Cobo Reinoso, S Grau Cerrato, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|November 22, 2021
Clinical management of cUTI, cIAI, and HABP/VABP attributable to carbapenem-resistant Gram-negative infections in SpainR Ferrer, M C Fariñas, E Maseda, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 9, 2016
The efficacy of fidaxomicin in the treatment of Clostridium difficile infection in a real-world clinical setting: a Spanish multi-centre retrospective cohortC Fehér, E Múñez Rubio, P Merino Amador, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|April 29, 2021
[A systematic review and expert's analysis of risk factors of infections in adults due to carbapenem-resistant Pseudomonas aeruginosa or Acinetobacter baumannii in Spain]R Ferrer, A Soriano, R Cantón, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Enfermedades Infecciosas Y Microbiologia Clinica|December 1, 1994
[Hip prosthesis infection: diagnostic approach and treatment of 27 cases]M Salavert, J Martínez, C Sánchez, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 29, 2015
Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patientsS Grau, J C Pozo, E Romá, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infections (CDI) also Known as Clostridium Difficile-Associated Diarrhoea (CDAD) in SpainJ Cobo Reinoso, S Grau Cerrato, J Mensa Pueyo, et al.
The British Journal of Dermatology|February 5, 2008
Amyloid elastosis: a new case studied extensively by electron microscopy and immunohistochemistryB Bocquier, M D'Incan, J Joubert, et al.
Medicina Cutanea Ibero-Latino-Americana|January 1, 1990
[Cutaneo-visceral leishmaniasis: a new opportunistic infection in patients infected by HIV]R Botella Estrada, O Sanmartín Jiménez, M I Febrer Bosch, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|January 20, 2007
Group A streptococcal bacteremia: outcome and prognostic factorsM Vallalta Morales, C J Soriano Navarro, M Salavert Lletí, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 27, 2015
Economic assessment of fidaxomicin for the treatment of Clostridium difficile infection (CDI) in special populations (patients with cancer, concomitant antibiotic treatment or renal impairment) in SpainC Rubio-Terrés, J Cobo Reinoso, S Grau Cerrato, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|November 22, 2021
Clinical management of cUTI, cIAI, and HABP/VABP attributable to carbapenem-resistant Gram-negative infections in SpainR Ferrer, M C Fariñas, E Maseda, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 9, 2016
The efficacy of fidaxomicin in the treatment of Clostridium difficile infection in a real-world clinical setting: a Spanish multi-centre retrospective cohortC Fehér, E Múñez Rubio, P Merino Amador, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|April 29, 2021
[A systematic review and expert's analysis of risk factors of infections in adults due to carbapenem-resistant Pseudomonas aeruginosa or Acinetobacter baumannii in Spain]R Ferrer, A Soriano, R Cantón, et al.
Pageof 12